Mark Lackner
Chief Tech/Sci/R&D Officer presso ZENTALIS PHARMACEUTICALS, INC.
Patrimonio netto: 3 M $ in data 31/03/2024
Profilo
Mark Lackner is currently the Chief Scientific Officer at Zentalis Pharmaceuticals, Inc. He previously worked as the VP, Head-Biology & Translational Sciences at IDEAYA Biosciences, Inc. Dr. Lackner obtained his doctorate degree from Stanford University in 1997.
He also holds undergraduate and graduate degrees from the University of Illinois At Urbana–Champaign, which were conferred in 1990 and 1991 respectively.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 02/02/2024 | 195 728 ( 0.28% ) | 3 M $ | 31/03/2024 |
Posizioni attive di Mark Lackner
| Società | Posizione | Inizio |
|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/12/2023 |
Precedenti posizioni note di Mark Lackner
| Società | Posizione | Fine |
|---|---|---|
| IDEAYA BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Formazione di Mark Lackner
| Stanford University | Doctorate Degree |
| University of Illinois At Urbana–Champaign | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| IDEAYA BIOSCIENCES, INC. | Health Technology |
| ZENTALIS PHARMACEUTICALS, INC. | Health Technology |
- Borsa valori
- Insiders
- Mark Lackner
